QVQ Holding BV

QVQ contributes to the accurate and sensitive detection of diseases in the early stages by providing top quality validated Imaging and Research Agents based on their C-Direct labeled single domain antibodies from camelids (professionally called functionalized VHH). To become a supplier of top-end market products, QVQ closely works together with top academic and industrial groups and actively stimulates research in these areas.